MedPath

Effects of ezetimibe on visceral fat in patients with metabolic syndrome: a randomized controlled study

Not Applicable
Conditions
metabolic syndrome
Registration Number
JPRN-UMIN000008548
Lead Sponsor
Enshu Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
78
Inclusion Criteria

Not provided

Exclusion Criteria

The exclusion criteria were: use of insulin, a history of hypersensitivity to ezetimibe, acute coronary syndrome and brain attacks (infarction or haemorrhage) within 3 months, secondary dyslipidaemia, familiar hypercholesterolaemia, pregnancy and severe hepatic, renal, active inflammatory and malignant diseases.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath